Medicare for All Act

What happened: Representative Jayapal (D-WA) introduced the Medicare for All Act (HR3069) on April 29, 2025, in the 119th Congress. The bill was referred to seven committees: Energy and Commerce, Ways and Means, Education and Workforce, Rules, Oversight and Government Reform, Armed Services, and the Judiciary. The bill text establishes a national health insurance program administered by HHS that covers all U.S. residents automatically, prohibits cost-sharing (deductibles, copayments, coinsurance), and eliminates private health insurance as a risk-bearing entity. The bill has 114 Democratic cosponsors — significant for a progressive bill but entirely within one party. No Republican cosponsors.

Money trail: This bill authorizes zero direct federal spending as drafted. It does not include tax increases, premium assessments, or appropriation language to fund the program — a critical legislative gap. The Congressional Budget Office would need to score the bill's revenue requirements if it advanced, but no funding mechanism is included in the introduced text. Authorization of the program is separate from appropriating the trillions of dollars required to replace $4.5 trillion in annual healthcare spending.

Structural winners and losers: The five managed care companies listed above face existential business model risk: $UNH, $CI, $HUM, $CNC, and $MOH derive the overwhelming majority of their revenue from private health insurance or government-managed care contracts. Pharmaceutical companies ($PFE, $JNJ, $MRK, $ABBV) face price control risk — the bill empowers HHS to negotiate drug prices under a single-payer system with monopsony power. Hospital systems face revenue disruption from the elimination of private insurance rates. These are structural, long-dated risks with near-zero legislative probability in this Congress.

Real market data analysis: Despite this bill's introduction on April 29, 2025, the real market data shows the opposite of a bearish reaction. $CNC surged 69.75% in 30 days to $53.98. $MOH gained 49.46% to $196.49. $HUM rose 46.46% to $243.12. $UNH jumped 41.62% to $370.74. These moves reflect unrelated catalysts — likely earnings beats, Medicaid redetermination resolution, or regulatory clarity on Medicare Advantage rate updates. The 7-day changes accelerated on the bill's introduction date (+4.56% for $UNH, +13.11% for $HUM, +12.47% for $MOH, +31.37% for $CNC), indicating the market views this bill's introduction as a non-event for near-term pricing.

Timeline: The bill is in the earliest legislative stage — referred to committee. The Republican-controlled House (119th Congress: 219R-215D-1 vacancy as of introduction) will not schedule hearings or markups on a single-payer bill. The bill will remain in committee until the end of the 119th Congress (January 2027) without further action. If Democrats gain unified control in the 2026 midterms (November 2026), this bill's reintroduction in the 120th Congress (2027-2029) would carry significantly higher probability. Near-term market impact: zero.